Search Results - "MARSH, S. G. E"

Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage by Lown, R N, Marsh, S G E, Switzer, G E, Latham, K A, Madrigal, J A, Shaw, B E

“…Despite over 20 million unrelated donors being listed worldwide, donor attrition at the confirmatory typing (CT) stage of donor acquisition is a key source of…”
Get full text

An update to the HLA Nomenclature Guidelines of the World Marrow Donor Association, 2012 by Bochtler, W, Maiers, M, Bakker, J N A, Baier, D M, Hofmann, J A, Pingel, J, Rist, H-G, Oudshoorn, M, Marsh, S G E, Müller, C R, Hurley, C K

“…For more than two decades, international cooperation and information technology have been playing key roles in the identification of suitable unrelated donors…”
Get full text

Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants by Shaw, B E, Mayor, N P, Szydlo, R M, Bultitude, W P, Anthias, C, Kirkland, K, Perry, J, Clark, A, Mackinnon, S, Marks, D I, Pagliuca, A, Potter, M N, Russell, N H, Thomson, K, Madrigal, J A, Marsh, S G E

“…Improving haematopoietic cell transplantation outcomes by selection of an HLA-matched unrelated donor is best practice; however, donor selection by secondary…”
Get full text

Single molecule real‐time DNA sequencing of HLA genes at ultra‐high resolution from 126 International HLA and Immunogenetics Workshop cell lines by Turner, T. R., Hayhurst, J. D., Hayward, D. R., Bultitude, W. P., Barker, D. J., Robinson, J., Madrigal, J. A., Mayor, N. P., Marsh, S. G. E.

“…The hyperpolymorphic HLA genes play important roles in disease and transplantation and act as genetic markers of migration and evolution. A panel of 107…”
Get full text

World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks by BOCHTLER, W, MAIERS, M, OUDSHOORN, M, MARSH, S. G. E, RAFFOUX, C, MUELLER, C, HURLEY, C. K

“…Since the advent of the European Marrow Donor Information System in the first half of the last decade, fully automated data exchange between registry computer…”
Get full text

Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice by Shaw, B E, Robinson, J, Fleischhauer, K, Madrigal, J A, Marsh, S G E

Get full text

BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation by Little, A-M., Green, A., Harvey, J., Hemmatpour, S., Latham, K., Marsh, S. G. E., Poulton, K., Sage, D.

“…Summary A review of the British Society for Histocompatibility and Immunogenetics (BSHI) “Guideline for selection and HLA matching of related, adult unrelated…”
Get full text

Nomenclature for factors of the HLA system, update March 2016 by Marsh, S. G. E.

Get full text

Nomenclature for factors of the HLA system, update May 2015 by Marsh, S. G. E.

Get full text

Nomenclature for factors of the HLA system, update June 2015 by Marsh, S. G. E.

Get full text

Nomenclature for factors of the HLA system, update February 2016 by Marsh, S. G. E.

Get full text

Nomenclature for factors of the HLA system, update January 2016 by Marsh, S. G. E.

Get full text

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles by Shaw, B E, Mayor, N P, Russell, N H, Apperley, J F, Clark, R E, Cornish, J, Darbyshire, P, Ethell, M E, Goldman, J M, Little, A-M, Mackinnon, S, Marks, D I, Pagliuca, A, Thomson, K, Marsh, S G E, Madrigal, J A

“…Disease stage and recipient/donor human leukocyte antigen (HLA) matching are important determinants of outcome in transplantation using volunteer-unrelated…”
Get full text

Nomenclature for factors of the HLA system, update April 2015 by Marsh, S. G. E.

Get full text

Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation by Shaw, B E, Lee, F, Krishnamurthy, S, Byrne, J L, Seedhouse, C, Mayor, N P, Maldonado-Torres, H, Saudemont, A, Marsh, S G E, Madrigal, J A, Russell, N H

“…Allo-SCT using unrelated donors is a curative treatment for patients with hematological disorders. The best donor is one matched for 10/10 HLA alleles, however…”
Get full text

16th International HLA and Immunogenetics Workshop (IHIW) Introduction by Middleton, D., Marsh, S. G. E.

Get full text

An update to HLA Nomenclature, 2010 by Marsh, S G E, Albert, E D, Bodmer, W F, Bontrop, R E, Dupont, B, Erlich, H A, Fernández-Viña, M, Geraghty, D E, Holdsworth, R, Hurley, C K, Lau, M, Lee, K W, Mach, B, Maiers, M, Mayr, W R, Müller, C R, Parham, P, Petersdorf, E W, Sasazuki, T, Strominger, J L, Svejgaard, A, Terasaki, P I, Tiercy, J M, Trowsdale, J

“…The WHO Nomenclature Committee for Factors of the HLA System met during the 15th International Histocompatibility and Immunogenetics Workshop in Buzios, Brazil…”
Get full text

World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks by Bochtler, W, Maiers, M, Bakker, J N A, Oudshoorn, M, Marsh, S G E, Baier, D, Hurley, C K, Müller, C R

“…A major goal of the World Marrow Donor Association (WMDA) is to foster international transplants of hematopoietic stem cells through the establishment of…”
Get full text

Nomenclature for factors of the HLA system, 2010 by Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Dupont, B., Erlich, H. A., Fernández-Viña, M., Geraghty, D. E., Holdsworth, R., Hurley, C. K., Lau, M., Lee, K. W., Mach, B., Maiers, M., Mayr, W. R., Müller, C. R., Parham, P., Petersdorf, E. W., Sasazuki, T., Strominger, J. L., Svejgaard, A., Terasaki, P. I., Tiercy, J. M., Trowsdale, J.

Get full text

Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products by Maiers, M, Bakker, J N A, Bochtler, W, Eberhard, H-P, Marsh, S G E, Müller, C, Rist, H-G

“…Nearly half of the unrelated hematopoietic SCTs facilitated worldwide involves an exchange of products between countries. The process is information intensive…”
Get full text